[Differentiated pharmacotherapy of gastroduodenal ulcers].
Tsimmerman
Ia S
IaS
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D045930:Anabolic Agents / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004968:Estrogens, Non-Steroidal / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use; D005746:Gastric Emptying / Q000187:drug effects; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D008901:Mineralocorticoids / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D045930:Anabolic Agents; D014151:Anti-Anxiety Agents; D000897:Anti-Ulcer Agents; D004968:Estrogens, Non-Steroidal; D005730:Ganglionic Blockers; D006635:Histamine H2 Antagonists; D008901:Mineralocorticoids; D010276:Parasympatholytics
Differentsirovannaia farmakoterapiia gastroduodenal'nykh iazv.